Table of Contents
What changed
Revenue rose 1.9% to NZ$4,064m, with operating profit up 21.9% to NZ$289m and PBT up 30.9% to NZ$237m. NPAT grew faster still at 41.3% to NZ$171m, helped by the effective tax rate falling from 31.5% to 26.6%. The cleaner operating read is PBT growth of ~31%.
Cash quality moved the other way. Operating cash flow fell 63.3% to NZ$157m (from NZ$428m), while capex almost doubled to NZ$156m (3.8% of revenue, up from 2.1%). Pre-lease free cash flow collapsed to approximately NZ$1m, versus NZ$346m in HY21. Inventories rose 43.5% to NZ$1,616m, lifting inventory days from 51 to 72. Cash on hand fell to NZ$409m from NZ$618m, and although gross borrowings eased to NZ$866m, net debt widened to NZ$457m from NZ$287m. The interim dividend was lifted 50% to 18.0 cps.
What matters
- Earnings quality vs. cash quality divergence. PBT up 31% is a genuine operating improvement, but ~NZ$1m of pre-lease FCF against NZ$171m NPAT (FCF/NPAT of 0.6%, down from 286%) means essentially none of the reported profit converted to cash this half.
- Inventory build is the dominant working-capital driver. The NZ$490m increase in inventories explains most of the operating cash shortfall. Whether this is a flagged, deliberate response to supply-chain disruption (as the release implies) or a demand-timing issue will determine whether cash conversion normalises in H2.
- Dividend funded from the balance sheet. At an 18.0 cps interim, payout is ~86% of NPAT but far exceeds pre-lease FCF. Combined with net debt rising NZ$170m, the lift in the interim dividend is effectively being carried by cash reserves rather than current-period cash generation.
Expectations
No quantified company target was disclosed. Seasonality context from FY21 shows the business is second-half weighted (H1 was 49.1% of FY21 revenue and only 39.7% of FY21 NPAT). HY22 annualised revenue of NZ$8.13b is essentially flat on FY21's NZ$8.12b, so top-line momentum over FY21 would need to come through second-half outperformance rather than H1 run-rate. The release points to a forward order book as qualitative support but does not quantify it, so there is no backlog-based check on FY22 shape from the extracted materials.
Quality of result
The earnings line is a mix of durable and assisted. The 21.9% lift in operating profit on 1.9% revenue growth implies real margin expansion, and that portion looks durable. However, ~10pp of the NPAT vs. PBT growth gap is a lower effective tax rate, which should not be extrapolated. Cash performance is clearly timing- and working-capital-driven: the NZ$271m fall in operating cash flow sits alongside a NZ$490m inventory build, so if stock is worked down into H2 volumes, conversion should recover; if not, the result looks flattered by inventory capitalising costs above the line. Capex intensity nearly doubling also sets a higher bar for FCF in H2.
Unresolved
- How much of the inventory build is deliberate supply-chain positioning versus slower-moving stock, and what is the expected unwind profile?
- What is management's EBIT margin trajectory target, and is the current margin expansion before or after significant items (the release cites "EBIT before significant items" but no full reconciliation was extracted)?
- Is the step-up in capex a one-half catch-up or a new run-rate, and what projects it supports?
- Given net debt rose NZ$170m while the dividend increased 50%, what is the internal leverage ceiling management is willing to operate to?
This briefing cannot assess segment-level profitability, forward-order-book size, or any quantified FY22 guidance, as none were provided in the extracted materials.
Key metrics
| Metric | HY22 | HY21 | Change |
|---|---|---|---|
| Revenue | $4064m | $3987m | +1.9% ↑ |
| Net profit after tax | $171m | $121m | +41.3% ↑ |
| Net cash inflow from operating activities | $157m | $428m | -63.3% ↓ |
| Interim dividend per share | 18.0c | 12.0c | +50.0% ↑ |
| Operating profit | $289m | $237m | +21.9% ↑ |
| Profit before tax | $237m | $181m | +30.9% ↑ |
| Cash and cash equivalents | $409m | $618m | -33.8% ↓ |
| Total assets | $7850m | $7766m | +1.1% ↑ |
Reference: annolyse.ai/briefings/fbu-hy22
Analytical metrics
| Metric | HY22 | HY21 | Context |
|---|---|---|---|
| PBT growth | +30.9% | — | cleaner earnings measure |
| Effective tax rate | 26.6% | 31.5% | — |
| FCF pre-lease | $1.0m | $346.0m | −$345.0m |
| FCF / NPAT | 0.6% | 285.9% | complementary conversion metric |
| Capex % revenue | 3.8% | 2.1% | — |
| Capex | $156.0m | $82.0m | +$74.0m |
| Inventory days | 72.4 | 51.4 | +21.0 days |
| Net debt | $457.0m | $287.0m | +$170.0m |
| Gross borrowings | $866.0m | $905.0m | −$39.0m |
| Payout ratio vs NPAT | 85.7% | — | — |
| ROE (annualised) | 9.2% | 6.7% | Strengthening |
| HY21 share of FY21 revenue | 49.1% | — | Other half was 50.9% |
| HY21 share of FY21 NPAT | 39.7% | — | Other half was 60.3% |
| Profit from continuing operations | $174.0m | $121.0m | +$53.0m |
Reference: annolyse.ai/briefings/fbu-hy22
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.